In this episode, an outline detailing the ideas and applications of Therapeutic Interchange in Bioequivalence and Generic Drugs and to review scientific tests for marketing permission of generic device is presented. Bioequivalence studies are very important for the drug happening phase for two together new drugs and generic equivalents in the drug industry. Their description and the results of common products are a important part of the enrollment dossier offered by regulatory authorities. The significance of bioequivalence studies is increasing again due to the big growth of the production and devouring of generic merchandise. Bioequivalence studies play a key role in constituting interchangeability (therapeutic similarity) and substitution of general drugs, allowing pharmacists to substitute ruling class without requiring prescriber authorization. These studies contribute to cost-influence, improve community health outcomes and boost access to essential drugs.
Author(s) Details:
Eva Troja,
Profarma
SH.A. Pharmaceutical Industry, Tirana, Albania.
Leonard
Deda,
Department
of Biomedical Sciences, Faculty of Medicine, University of Medicine, Tirana,
Albania.
Please see the link here: https://stm.bookpi.org/NAPR-V8/article/view/11657
No comments:
Post a Comment